Peripheral White Blood Cell Subsets in Metastatic Colorectal Cancer Patients Treated with Cetuximab: The Potential Clinical Relevance-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Peripheral White Blood Cell Subsets in Metastatic Colorectal Cancer Patients Treated with Cetuximab: The Potential Clinical Relevance

Published:2018-01-04 Issue: Volume:8 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Matić Ivana Z.,Kolundžija Branka,Damjanović Ana,Spasić Jelena,Radosavljević Davorin,Đorđić Crnogorac Marija,Grozdanić Nađa,Juranić Zorica D.

Funder

Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference25 articles.

1. Cetuximab, a chimeric human mouse anti-epidermal growth factor receptor monoclonal antibody, in the treatment of human colorectal cancer;Galizia;Oncogene,2007

2. Cetuximab: from bench to bedside;Vincenzi;Curr Cancer Drug Targets,2010

3. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer;Van Cutsem;Ann Oncol,2016

4. Progress in metastatic colorectal cancer: growing role of cetuximab to optimize clinical outcome;García-Foncillas;Clin Transl Oncol,2010

5. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer;Van Cutsem;N Engl J Med,2009

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of the tissue infiltrated and peripheral blood immune cell subsets with response to radiotherapy for rectal cancer;BMC Medical Genomics;2022-05-09

2. Biomarkers in Human Peripheral Blood Mononuclear Cells: The State of the Art in Amyotrophic Lateral Sclerosis;International Journal of Molecular Sciences;2022-02-25

3. Circulating P2X7 Receptor Signaling Components as Diagnostic Biomarkers for Temporal Lobe Epilepsy;Cells;2021-09-16

4. White blood cell subsets in HER2-positive breast cancer patients treated with trastuzumab in relation to clinical outcome;Pathology - Research and Practice;2021-08

5. Natural killer cells as a double-edged sword in cancer immunotherapy: A comprehensive review from cytokine therapy to adoptive cell immunotherapy;Pharmacological Research;2020-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3